Experts Call for Rapid Improvements in Diagnosis, Treatment of Bile Duct Cancer

Experts call for rapid improvements in diagnosis, treatment of bile duct cancer

The international group of experts, including Professor John Bridgewater (UCL Cancer Institute), is calling for rapid improvements in diagnosis, treatment and research for cholangiocarcinoma, also known as bile duct cancer.

Experts call to improve survival rates for bile duct cancer patients

The international group of experts, including Professor John Bridgewater (UCL Cancer Institute), is calling for rapid improvements in diagnosis, treatment and research for cholangiocarcinoma, also known as bile duct cancer. Bile duct cancer is a rare but aggressive disease that starts in the small tubes that carry digestive fluid from your liver to intestines. These tumors usually develop and progress silently, meaning most people are diagnosed …

Call to improve survival rates for bile duct cancer patients

Survival rates for people with cholangiocarcinoma, a silent but deadly form of cancer originating in the bile ducts, are dismal and a new approach is needed, argues a panel of leading experts including a UCL researcher. The international group of experts, including Professor John Bridgewater (UCL Cancer Institute), is calling for rapid improvements in diagnosis, treatment and research for cholangiocarcinoma, also known as bile duct cancer. Bile …

Urgent Appeal to Enhance Survival Outcomes for Bile Duct Cancer Patients

Cholangiocarcinoma, commonly known as bile duct cancer, remains one of the most challenging malignancies in oncology due to its aggressive nature, late diagnosis, and poor prognosis. Originating within the intricate network of bile ducts that transport bile from the liver to the small intestine, this cancer often progresses silently, evading early clinical detection and rendering curative treatments rare. The global medical community, spearheade…